Sphera Funds Management Ltd.
- SEC CIK
- 0001496201
- Latest filing
- Aug 14, 2026
Holdings in Q1 2025
Holdings as of Mar 31, 2025, filed May 15, 2025. Long positions only; changes compare share counts with Q4 2024.
- Positions
- 112
- +9 vs. Q4 2024
- Portfolio value
- $405.5M
- −$136.0M (−25.1%) vs. Q4 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,572,181 | $24.2M | 6.0% | +3,000+0.2% | Added | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 1,663,974 | $20.4M | 5.0% | +282,733+20.5% | Added | History |
| SNYSanofi | SPONSORED ADR | 304,515 | $16.9M | 4.2% | −80,000−20.8% | Reduced | History |
| NVMINova Ltd. | COM | 90,697 | $16.7M | 4.1% | +22,551+33.1% | Added | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 175,060 | $12.9M | 3.2% | −50,000−22.2% | Reduced | History |
| BBIOBridgeBio Pharma, Inc. | COM | 366,608 | $12.7M | 3.1% | −538,671−59.5% | Reduced | History |
| SRPTSarepta Therapeutics, Inc. | COM | 157,931 | $10.1M | 2.5% | +59,010+59.7% | Added | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 267,385 | $9.68M | 2.4% | +38,609+16.9% | Added | History |
| LLYEli Lilly & Co | Stock | 11,690 | $9.65M | 2.4% | −1,500−11.4% | Reduced | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 507,829 | $9.22M | 2.3% | +33,726+7.1% | Added | History |
| JNJJohnson & Johnson | Stock | 52,831 | $8.76M | 2.2% | −17,000−24.3% | Reduced | History |
| NVONovo Nordisk A S | ADR | 118,080 | $8.20M | 2.0% | +20,000+20.4% | Added | History |
| ELDNEledon Pharmaceuticals, Inc. | COM | 2,307,119 | $7.82M | 1.9% | −244,500−9.6% | Reduced | History |
| MLYSMineralys Therapeutics, Inc. | COM | 465,526 | $7.39M | 1.8% | +274,854+144.2% | Added | History |
| AMZNAmazon Com Inc | Stock | 36,607 | $6.96M | 1.7% | −26,000−41.5% | Reduced | History |
| ABBVAbbVie Inc. | Stock | 30,256 | $6.34M | 1.6% | −4,000−11.7% | Reduced | History |
| PHVSPharvaris N.V. | COM | 383,856 | $6.03M | 1.5% | −4,327−1.1% | Reduced | History |
| ORAOrmat Technologies, Inc. | COM | 84,000 | $5.94M | 1.5% | +5,000+6.3% | Added | History |
| CYTKCytokinetics Inc | COM NEW | 144,961 | $5.83M | 1.4% | −8,060−5.3% | Reduced | History |
| METAMeta Platforms, Inc. | Stock | 9,962 | $5.74M | 1.4% | −11,039−52.6% | Reduced | History |
| NVSNovartis AG | ADR | 50,000 | $5.57M | 1.4% | 00.0% | Unchanged | History |
| MRKMerck & Co., Inc. | Stock | 59,600 | $5.35M | 1.3% | 00.0% | Unchanged | History |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 140,660 | $5.33M | 1.3% | +49,077+53.6% | Added | History |
| Ormat Technologies, Inc.686688AC6 | DEBT 2.500% 7/1 | 5,037,000 | $5.23M | 1.3% | 00.0% | Unchanged | – |
| NICENICE Ltd. | SPONSORED ADR | 33,303 | $5.13M | 1.3% | −9,197−21.6% | Reduced | History |
| GSKGSK plc | ADR | 130,000 | $5.04M | 1.2% | 00.0% | Unchanged | History |
| SEDGSolaredge Technologies, Inc. | COM | 309,216 | $5.00M | 1.2% | −65,784−17.5% | Reduced | History |
| ETNB89bio, Inc. | COM | 618,343 | $4.50M | 1.1% | +61,811+11.1% | Added | History |
| MRUSMerus N.V. | COM | 106,532 | $4.48M | 1.1% | −24,000−18.4% | Reduced | History |
| IMTXImmatics N.V. | SHS | 921,111 | $4.15M | 1.0% | 00.0% | Unchanged | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 181,346 | $3.97M | 1.0% | −24,905−12.1% | Reduced | History |
| MAZEMaze Therapeutics, Inc. | COM | 355,554 | $3.91M | 1.0% | +355,554 | New | History |
| TVTXTravere Therapeutics, Inc. | COM | 200,000 | $3.58M | 0.9% | −20,700−9.4% | Reduced | History |
| SVRASavara Inc | COM | 1,284,151 | $3.56M | 0.9% | +72,618+6.0% | Added | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 277,550 | $3.54M | 0.9% | +80,000+40.5% | Added | History |
| DYNDyne Therapeutics, Inc. | COM | 329,262 | $3.44M | 0.8% | +93,000+39.4% | Added | History |
| ANNXAnnexon, Inc. | COM | 1,764,387 | $3.41M | 0.8% | +521,348+41.9% | Added | History |
| JANXJanux Therapeutics, Inc. | COM | 125,840 | $3.40M | 0.8% | +57,507+84.2% | Added | History |
| HELPHelus Pharma Inc. | COM NEW | 527,222 | $3.34M | 0.8% | −10,889−2.0% | Reduced | History |
| IMVTImmunovant, Inc. | COM | 194,638 | $3.33M | 0.8% | +194,638 | New | History |
| NVDANVIDIA Corp | Stock | 29,605 | $3.21M | 0.8% | +29,605 | New | History |
| RZLTRezolute, Inc. | COM NEW | 1,081,447 | $3.14M | 0.8% | −84,448−7.2% | Reduced | History |
| Avidity Biosciences, Inc.05370A108 | COM | 106,000 | $3.13M | 0.8% | +106,000 | New | – |
| AMGNAmgen Inc | Stock | 10,000 | $3.12M | 0.8% | +10,000 | New | History |
| BIIBBiogen Inc. | COM | 22,738 | $3.11M | 0.8% | 00.0% | Unchanged | History |
| ACOGAlpha Cognition Inc. | COM NEW | 596,992 | $3.02M | 0.7% | −23,008−3.7% | Reduced | History |
| VIGLVigil Neuroscience, Inc. | COM | 1,604,429 | $2.86M | 0.7% | +102,000+6.8% | Added | History |
| NTLAIntellia Therapeutics, Inc. | COM | 381,080 | $2.71M | 0.7% | −85,000−18.2% | Reduced | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 334,987 | $2.66M | 0.7% | 00.0% | Unchanged | History |
| AMATApplied Materials Inc | Stock | 18,000 | $2.61M | 0.6% | +18,000 | New | History |
| SRRKScholar Rock Holding Corp | COM | 78,193 | $2.51M | 0.6% | −12,000−13.3% | Reduced | History |
| CRMSalesforce, Inc. | Stock | 9,100 | $2.44M | 0.6% | +9,100 | New | History |
| BHVNBiohaven Ltd. | COM | 99,784 | $2.40M | 0.6% | −56,710−36.2% | Reduced | History |
| ENGNenGene Therapeutics Inc. | COM | 528,365 | $2.37M | 0.6% | −31,635−5.6% | Reduced | History |
| SKYESkye Bioscience, Inc. | COM NEW | 1,476,353 | $2.35M | 0.6% | −88,275−5.6% | Reduced | History |
| WDAYWorkday, Inc. | CL A | 10,000 | $2.34M | 0.6% | 00.0% | Unchanged | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 52,009 | $2.30M | 0.6% | −47,991−48.0% | Reduced | History |
| PFEPfizer Inc | Stock | 90,000 | $2.28M | 0.6% | 00.0% | Unchanged | History |
| KURAKura Oncology, Inc. | COM | 343,522 | $2.27M | 0.6% | −266,565−43.7% | Reduced | History |
| ELVNEnliven Therapeutics, Inc. | COM | 111,743 | $2.20M | 0.5% | +111,743 | New | History |
| TSEMTower Semiconductor Ltd | SHS NEW | 61,549 | $2.19M | 0.5% | −104,600−63.0% | Reduced | History |
| UBERUber Technologies, Inc | Stock | 30,000 | $2.19M | 0.5% | 00.0% | Unchanged | History |
| GOOGAlphabet Inc. | Stock | 13,500 | $2.11M | 0.5% | −30,000−69.0% | Reduced | History |
| VKTXViking Therapeutics, Inc. | COM | 83,270 | $2.01M | 0.5% | −20,000−19.4% | Reduced | History |
| COGTCogent Biosciences, Inc. | COM | 335,024 | $2.01M | 0.5% | +335,024 | New | History |
| VTGNVistagen Therapeutics, Inc. | COM | 790,550 | $1.98M | 0.5% | −18,000−2.2% | Reduced | History |
| AVGOBroadcom Inc. | Stock | 11,695 | $1.96M | 0.5% | −5,185−30.7% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 63,821 | $1.93M | 0.5% | 00.0% | Unchanged | History |
| NKENIKE, Inc. | Stock | 30,050 | $1.91M | 0.5% | +30,050 | New | History |
| CHKPCheck Point Software Technologies Ltd | ORD | 8,334 | $1.90M | 0.5% | −27,301−76.6% | Reduced | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 271,792 | $1.81M | 0.4% | 00.0% | Unchanged | History |
| MSFTMicrosoft Corp | Stock | 4,592 | $1.72M | 0.4% | −17,735−79.4% | Reduced | History |
| NTRNutrien Ltd. | COM | 30,894 | $1.53M | 0.4% | −25,000−44.7% | Reduced | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 84,000 | $1.45M | 0.4% | +84,000 | New | History |
| WIXWix.com Ltd. | SHS | 8,800 | $1.44M | 0.4% | −30,453−77.6% | Reduced | History |
| FROGJFrog Ltd | Stock | 42,871 | $1.37M | 0.3% | −147,510−77.5% | Reduced | History |
| CAMTCamtek Ltd | ORD | 23,086 | $1.35M | 0.3% | −13,201−36.4% | Reduced | History |
| PMNProMIS Neurosciences Inc. | COM | 1,929,297 | $1.34M | 0.3% | 00.0% | Unchanged | History |
| SHL Telemedicine Ltd78423T200 | ADS | 632,456 | $1.31M | 0.3% | 00.0% | Unchanged | – |
| ORICOric Pharmaceuticals, Inc. | COM | 234,834 | $1.31M | 0.3% | −38,379−14.0% | Reduced | History |
| CEVACeva Inc | COM | 48,920 | $1.25M | 0.3% | +48,920 | New | History |
| BMYBristol Myers Squibb Co | Stock | 20,000 | $1.22M | 0.3% | 00.0% | Unchanged | History |
| VTYXVentyx Biosciences, Inc. | COM | 1,012,749 | $1.16M | 0.3% | 00.0% | Unchanged | History |
| NNDMNano Dimension Ltd. | SPONSORD ADS NEW | 717,518 | $1.14M | 0.3% | +717,518 | New | History |
| INZYInozyme Pharma, Inc. | COM | 1,191,140 | $1.08M | 0.3% | 00.0% | Unchanged | History |
| OTLKOutlook Therapeutics, Inc. | Stock | 857,142 | $1.05M | 0.3% | +857,142 | New | History |
| ATXSAstria Therapeutics, Inc. | COM | 189,800 | $1.01M | 0.2% | +50,000+35.8% | Added | History |
| CMMBChemomab Therapeutics Ltd. | SPONSORED ADS | 900,428 | $981.5K | 0.2% | −314,147−25.9% | Reduced | History |
| CATXPerspective Therapeutics, Inc. | COM NEW | 460,247 | $980.3K | 0.2% | 00.0% | Unchanged | History |
| MRVLMarvell Technology, Inc. | COM | 15,070 | $927.9K | 0.2% | −63,541−80.8% | Reduced | History |
| ARVNArvinas, Inc. | COM | 125,000 | $877.5K | 0.2% | +125,000 | New | History |
| XENEXenon Pharmaceuticals Inc. | COM | 26,097 | $875.6K | 0.2% | −26,000−49.9% | Reduced | History |
| PERIPerion Network Ltd. | SHS NEW | 102,612 | $835.3K | 0.2% | 00.0% | Unchanged | History |
| RGLSRegulus Therapeutics Inc. | COM | 452,845 | $792.5K | 0.2% | +452,845 | New | History |
| LRMRLarimar Therapeutics, Inc. | COM | 366,304 | $787.6K | 0.2% | −89,300−19.6% | Reduced | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 205,859 | $654.6K | 0.2% | −294,632−58.9% | Reduced | History |
| HOWLWerewolf Therapeutics, Inc. | COM | 626,810 | $609.4K | 0.2% | 00.0% | Unchanged | History |
| VIRVir Biotechnology, Inc. | COM | 90,855 | $588.7K | 0.1% | −490,974−84.4% | Reduced | History |
| APREAprea Therapeutics, Inc. | COM NEW | 270,000 | $550.8K | 0.1% | 00.0% | Unchanged | History |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 421,229 | $543.4K | 0.1% | −269,489−39.0% | Reduced | History |
Options (3)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q4 2024 (9)
Positions held at the end of Q4 2024 that are gone from this filing.
| Security | Class | Shares in Q4 2024 | Value in Q4 2024 | % of portfolio in Q4 2024 | History |
|---|---|---|---|---|---|
| ACADAcadia Pharmaceuticals Inc | COM | 288,539 | $5.29M | 1.0% | History |
| PLRXPliant Therapeutics, Inc. | COM | 297,362 | $3.92M | 0.7% | History |
| ENPHEnphase Energy, Inc. | Stock | 50,198 | $3.45M | 0.6% | History |
| CRGXCARGO Therapeutics, Inc. | COM | 179,674 | $2.59M | 0.5% | History |
| CGEMCullinan Therapeutics, Inc. | COM | 205,000 | $2.50M | 0.5% | History |
| MRSNMersana Therapeutics, Inc. | COM | 690,272 | $987.1K | 0.2% | History |
| ALMSAlumis Inc. | COM | 125,000 | $982.5K | 0.2% | History |
| KYTXKyverna Therapeutics, Inc. | COM | 118,758 | $444.2K | 0.1% | History |
| CGENCompugen Ltd | ORD | 177,094 | $271.0K | 0.1% | History |